Researchers in Seattle are building a “biobank” of samples from patients to help speed up a vaccine and unlock the mystery of why COVID-19 hits some harder than others.
ADVERTISEMENT
ADVERTISEMENT

Researchers in Seattle are building a “biobank” of samples from patients to help speed up a vaccine and unlock the mystery of why COVID-19 hits some harder than others.